If you’ve been searching for menopause support online, you’ve likely encountered Gennev, one of the earliest telehealth platforms dedicated to women’s hormonal health. But as the landscape of women’s health evolves, understanding how different providers approach hormone imbalance becomes essential for making informed decisions. While Gennev offers valuable services for menopausal women, providers like Inner Balance have emerged with comprehensive solutions that address hormonal concerns at their root cause, including innovative products like Oestra™, which combines bioidentical estradiol and progesterone in a single vaginal cream for superior absorption.
Key Takeaways
- Gennev strengths: Accepts insurance through several major plans, including Aetna, Anthem, Cigna, and UnitedHealthcare, offers integrated registered dietitian support, established since 2016 with strong verified patient reviews, including a 4.8/5 rating from more than 6,400 patient reviews
- Gennev focus: Specializes in menopause care, which may not serve women with PCOS, endometriosis, or postpartum hormonal concerns
- Delivery method matters: Vaginal hormone delivery can provide a higher proportion of active, unconjugated estrogen than oral therapy while reducing first-pass liver conversion
- All-in-one solutions exist: Some providers now offer combination bioidentical creams that address multiple hormones simultaneously, eliminating the need for multiple prescriptions
- Beyond menopause: Modern telehealth platforms increasingly treat hormonal imbalances across all life stages, from the 20s through menopause and beyond
Oestra®
A prescription vaginal hormone cream formulated to treat hormonal imbalance and relieve your specific symptoms.
6-month money back •
Free shipping • Cancel anytime
Understanding Hormone Replacement Therapy Needs in 2026
The Signs Your Body Is Asking for Help
Hormonal imbalance doesn’t announce itself with a single symptom. It manifests as a constellation of changes:
- Brain fog that makes you forget why you walked into a room
- Sleep disruption that leaves you exhausted despite eight hours in bed
- Mood swings that feel completely out of character
- Weight gain that persists despite careful eating
- Heavy or painful periods
- Vaginal dryness and declining libido
- Visible skin aging
Research confirms that these symptoms share a common thread: shifting hormone levels that can begin changing earlier than menopause. The conventional medical system often fails to connect these dots, treating each symptom separately with different specialists and medications rather than addressing the underlying hormonal cause.
Why Traditional Approaches Fall Short
The standard medical response to hormonal symptoms typically involves waiting until menopause officially begins, prescribing separate medications for each complaint, or suggesting birth control pills that actually suppress hormones. Women with perimenopause, PCOS, or endometriosis often find themselves caught in a gap where they’re “too young” for hormone therapy but clearly symptomatic.
This is where evaluating different telehealth providers becomes crucial. Some, like Gennev, focus exclusively on perimenopausal and menopausal women. Others have expanded their scope to treat hormonal imbalances across the lifespan, recognizing that a 28-year-old with endometriosis and a 52-year-old in menopause may both benefit from bioidentical hormone support.
How Gennev Approaches Menopause Care
What Gennev Offers
Gennev launched in 2016 as one of the first dedicated virtual menopause clinics, filling a genuine need for specialized care. The platform connects women with board-certified OB/GYNs who understand menopause, offers registered dietitian consultations, and accepts major insurance plans including Aetna, Anthem, Cigna, and UnitedHealthcare.
For women with insurance coverage, Gennev’s model can significantly reduce out-of-pocket costs. Initial consultations run approximately $250 for self-pay patients, with follow-up visits at $199. Insurance copays typically range from $30 to $75. The platform has helped thousands of women access menopause care.
Understanding Different Care Models
Several important considerations emerge when evaluating different approaches to hormonal health:
Medication costs and prescriptions: Some platforms charge visit fees separately from prescriptions, which you fill at your regular pharmacy. Others include compounded medications shipped directly to your door. Understanding which model works best for your insurance and preferences matters.
Single vs. multiple prescriptions: If you need both estrogen and progesterone, some providers prescribe separate products for each, requiring coordination of multiple refills and dosing schedules. Other providers offer combination formulations that deliver both hormones together.
Treatment scope: Some platforms specialize exclusively in menopause, while others treat hormonal imbalances across all life stages, including PCOS, endometriosis, and postpartum hormonal changes.
Delivery method optimization: While many providers offer pills, patches, and vaginal options, some specialize in optimizing delivery for maximum absorption and targeted action.
The Power of Bioidentical Hormones and Vaginal Delivery
Why Delivery Method Transforms Results
How you receive hormones matters as much as which hormones you take. Research on vaginal drug delivery demonstrates that the vaginal mucosa provides direct bloodstream access, bypassing first-pass liver metabolism. This matters because oral hormones face significant liver processing before reaching target tissues.
Pharmacokinetic research comparing delivery routes shows vaginal administration can provide a higher proportion of active, unconjugated estrogen than oral therapy while reducing first-pass liver conversion. The remaining oral hormone gets converted to less beneficial forms or metabolites that can cause side effects like drowsiness and mood instability.
The First Uterine Pass Effect
Beyond general absorption advantages, research on vaginal hormone delivery reveals a phenomenon called the “first uterine pass effect.” Hormones placed in the upper vagina preferentially reach the uterus before circulating elsewhere, creating higher tissue concentrations exactly where they’re needed most.
This targeted delivery may help support endometrial exposure and cycle regulation while allowing clinicians to use lower, more targeted dosing than some oral regimens require.
All-in-One vs. Multiple Prescriptions
One significant advancement in women’s hormone therapy involves combination formulations that deliver both estradiol and progesterone together. Inner Balance’s Oestra™ represents this approach, providing bioidentical estradiol and micronized progesterone in a single vaginal cream.
This all-in-one model eliminates the complexity of managing separate prescriptions, ensures proper hormone ratios, and optimizes delivery for enhanced absorption. According to Inner Balance data, the majority of users report improved vaginal dryness, better sleep, and mental health improvements.
Addressing Early Signs of Hormonal Decline
When Symptoms Start Earlier Than Expected
Hormones don’t wait until your 50s to change. Clinical evidence shows progesterone patterns can become less consistent as ovulation changes during the menopause transition, often before estrogen decline becomes steady. This explains why women in their late 30s and 40s experience symptoms they’re repeatedly told are “too early” for hormone therapy.
Signs of early perimenopause include:
- Cycles becoming shorter or longer than usual
- Heavier bleeding or new spotting
- Sleep quality declining without obvious cause
- Anxiety or mood changes unrelated to circumstances
- Brain fog and difficulty concentrating
- Fatigue despite adequate rest
Supporting Hormonal Balance in Your 30s and 40s
For younger women with hormonal concerns, treatment options depend heavily on which provider you choose. Platforms with a menopause-only focus may not serve a 35-year-old with PCOS-related hormone imbalance or a 32-year-old struggling with endometriosis.
Providers treating hormonal conditions beyond menopause can offer bioidentical hormone support regardless of age or specific diagnosis. This broader approach recognizes that hormone imbalance is the root cause of symptoms across multiple conditions, and restoring balance addresses them comprehensively.
Beyond Hormones: Solutions for Low Libido
When Hormone Therapy Isn’t Enough for Desire
Many women find that even with optimized hormone levels, their desire feels flat. This occurs because female sexuality involves both hormonal foundations and neurological pathways. Estrogen and progesterone support the physical capacity for arousal, but the spark of desire originates in the brain.
Low libido affects millions of women, often described as feeling like “my spark is gone” or “I love my partner, but I never feel like it.” This disconnection between emotional love and physical desire points to brain-based pathways that hormones alone don’t fully address.
Dual-Pathway Approaches to Desire
Innovative approaches combine bremelanotide, which activates melanocortin receptors to boost dopamine, motivation, and arousal, with oxytocin, which supports bonding, emotional connection, and relational warmth. This dual-pathway formulation addresses both neurochemical desire and emotional readiness for intimacy.
Unlike injectable alternatives costing $250 or more per use, newer sublingual tablet formats offer convenience at approximately $8 to $10 per experience. These work on-demand, approximately 45 to 60 minutes before intimacy, with effects that may last up to 72 hours for some women. The non-hormonal formula complements hormone therapy without replacing it.
Hormone-Informed Skincare Solutions
Why Skin Ages Hormonally
Visible skin aging accelerates during perimenopause and menopause as declining estrogen reduces collagen production, skin elasticity, and hydration. Research on hormonally aging skin shows that addressing DHT pathways, collagen synthesis, and cell turnover at the hormonal level produces results topical serums cannot match.
BodyMatched™ Anti-Aging Face Cream approaches skin aging through bioidentical estriol combined with clinically proven anti-aging compounds. Clinical data demonstrates significant improvement in skin elasticity, firmness, wrinkle depth, and pore size, outcomes that reflect hormone-informed formulation rather than cosmetic-only approaches.
Comprehensive hormone optimization addresses skin from both directions. Internal hormone restoration through Oestra™ supports systemic estrogen levels that influence collagen throughout the body. Topical BodyMatched delivers targeted estriol directly to facial skin for localized benefit. Together, they represent a holistic strategy conventional skincare lines cannot replicate.
Telehealth and Personalized Care Models
The Shift to Digital Women’s Health
Both Gennev and newer providers like Inner Balance demonstrate telehealth’s power to reach women previously underserved by conventional medicine. The ability to consult board-certified physicians from home, receive prescriptions without clinic visits, and access ongoing support through care teams transforms hormone therapy accessibility.
Key differences emerge in how platforms structure care:
Consultation models: Some offer 30-minute initial appointments, while others provide 60-minute deep dives. Follow-up accessibility varies from unlimited messaging to per-visit fees.
Treatment scope: Menopause-only platforms serve that population well but may leave younger women seeking alternatives. Comprehensive platforms treat hormonal conditions across the lifespan.
Medication delivery: Some prescribe to external pharmacies, while others include compounded medications shipped directly to your door, simplifying adherence and eliminating pharmacy coordination.
Symptom-Based vs. Lab-Based Treatment
Progressive providers increasingly recognize that symptoms matter more than labs. Laboratory hormone testing captures a single moment and can have accuracy limitations. How you feel day-to-day provides reliable guidance for treatment optimization.
This patient-centered approach means adjusting doses based on energy, sleep, mood, and symptom relief rather than chasing arbitrary “normal” ranges that may not reflect your individual needs.
Making an Informed Decision
When Comprehensive Solutions Better Fit Your Needs
Consider broader options if you:
- Experience hormonal symptoms but aren’t yet in perimenopause
- Have PCOS, endometriosis, or postpartum imbalance
- Have tried oral HRT without adequate relief and want to explore vaginal delivery
- Want all-in-one formulations rather than multiple prescriptions
- Are concerned about bioavailability and delivery optimization
- Seek solutions for low libido, skin aging, or cellular energy alongside hormone balance
ACOG guidance notes that estrogen route matters, with oral estrogen having a stronger prothrombotic effect than some non-oral routes. For systemic vaginal hormone therapy, safety should still be reviewed individually with a clinician.
Oestra®
A prescription vaginal hormone cream formulated to treat hormonal imbalance and relieve your specific symptoms.
6-month money back •
Free shipping • Cancel anytime
Frequently Asked Questions
How does Gennev’s pricing compare to all-in-one hormone solutions?
Gennev charges approximately $250 for initial consultations and $199 for follow-ups, or insurance copays if covered, plus separate pharmacy costs for each prescription. All-in-one solutions like Oestra™ include consultation, ongoing support, and medication in a single price: approximately $199/month for the first six months, dropping to $99/month thereafter. Total first-year costs often end up comparable, though Gennev may cost less for well-insured patients. Oestra offers a 180-day money-back guarantee, reducing financial risk for those trying bioidentical therapy.
Can I switch from Gennev to another provider mid-treatment?
Yes. Medical records transfer easily between telehealth platforms, and new providers will review your current regimen before making recommendations. There’s no need to “start over,” and transitions typically happen within one to two weeks. Most platforms, including Inner Balance, welcome patients who’ve tried other approaches, often finding better solutions by optimizing delivery methods or addressing previously untreated symptoms.
Why don’t more providers offer vaginal combination hormone creams?
Compounding bioidentical estradiol and progesterone into a single vaginal formulation requires specialized 503A or 503B pharmacy partnerships, physician expertise in dosing ratios, and infrastructure for direct-to-patient medication delivery. Traditional menopause care relies on separate FDA-approved products, such as oral estrogen pills, progesterone capsules, and vaginal estrogen tablets, because they’re familiar and often insurance-covered, not necessarily because they’re optimal for absorption and effectiveness.
What if I have symptoms but I’m told I’m “too young” for hormone therapy?
Hormone patterns can change before official menopause, and symptoms don’t wait for arbitrary age cutoffs. Providers focused exclusively on menopause may not treat you, but comprehensive platforms recognize that perimenopause, PCOS, endometriosis, and postpartum hormonal changes all involve hormone imbalances treatable with bioidentical support. If one provider dismisses your concerns, seek care from those treating the root cause rather than age-based criteria.
Is vaginal hormone therapy safe for long-term use?
Long-term safety depends on the specific formulation, dosing, and individual health factors. ACOG guidance notes that non-oral estrogen routes avoid some risks associated with oral estrogen, particularly regarding venous thromboembolism. The best approach is to work with a provider who monitors your response, adjusts treatment as needed, and reviews safety considerations specific to your health profile and goals.
